Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

5-year impact of new registered indications on the ESMO-MCBS

Long term follow-up on single arm registration studies: what have we learned?

Date

09 Sep 2022

Session

5-year impact of new registered indications on the ESMO-MCBS

Topics

Cancer Care Equity Principles and Health Economics

Tumour Site

Presenters

Bishal Gyawali

Authors

B. Gyawali

Author affiliations

  • Medical Oncology Department, KAHS - Karnali Academy of Health Sciences, 21200 - Chandannath/NP
More

Resources

Login to access the resources on OncologyPRO.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.